GlassScriptPhysician profile
Gaurav Gupta
NPI 1376745711
$8,608.20
in general payments reported to CMS, 2019-2025
39 companies · $1,002 in 2025
The $1,002 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,945 · 2020: $838 · 2021: $779 · 2022: $1,622 · 2023: $803 · 2024: $618 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,424.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,328.42 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $1,162.72 | 2019-2024 | (Ck7) Extended Holter |
| Abbott Laboratories | $987.43 | 2019-2025 | Xience Skypoint, Perclose Proglide, Diamondback Peripheral |
| Biotronik INC. | $785.40 | 2019-2025 | Orsiro Mission, Pulsar-18 T3, Passeo-18 |
| Janssen Pharmaceuticals, INC | $465.47 | 2019-2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $442.10 | 2020-2023 | Biograph Horizon-3r |
| Amgen INC. | $336.92 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $244.00 | 2022-2023 | Lutonix Drug Coated Balloon |
| Abiomed | $239.25 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $227.39 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $211.94 | 2019-2024 | |
| Medtronic, INC. | $208.72 | 2021-2025 | Symplicity G3 |
| Medtronic Vascular, INC. | $207.45 | 2019-2020 | |
| Pfizer INC. | $200.90 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.92 | 2019-2025 | Lifevest |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.